Mandate

Vinge has advised Stenhus Fastigheter i Norden AB in connection with their uplisting to Nasdaq Stockholm

Vinge has advised Stenhus Fastigheter i Norden AB (publ) (“Stenhus Fastigheter” or the “Company”) in connection with the Company's uplisting to Nasdaq Stockholm. The first day of trading on Nasdaq Stockholm was 18 December 2024.

Stenhus Fastigheter is a real estate company that owns and manages public properties and commercial properties with a clear geographic focus on urban areas and growth cities. Stenhus Fastigheter also works actively with existing and potential building rights within the current portfolio.

Vinge’s team consisted mainly of Rikard Lindahl, Joel Magnusson and Michaela Ådén (Capital Markets and Public M&A), Diana Kanold (VDR), Victor Ericsson, Emelie Svanberg, Marcus Svärd and Ellenor Eckerborn (Tax), Nicklas Thorgerzon and Siri Blomberg (IT och GDPR), Ebba Svenburg and Jonna Skog (Employment), Kristoffer Larson, Madelene Andersson and Sara Franson (Real Estate), Lina Österberg (Environment), Ida Redander, August Ahlin and William Carlberg Johansson (Banking and Finance) and Hayaat Ibrahim and Jonna Fransson (Compliance).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025